Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Май 6, 2024
Abstract
Background
Elevated
interstitial
fluid
pressure
within
tumors,
resulting
from
impaired
lymphatic
drainage,
constitutes
a
critical
barrier
to
effective
drug
penetration
and
therapeutic
outcomes.
Results
In
this
study,
based
on
the
photosynthetic
characteristics
of
algae,
an
active
carrier
(CP@ICG)
derived
Chlorella
pyrenoidos
(CP)
was
designed
constructed.
Leveraging
hypoxia
tropism
phototropism
exhibited
by
CP,
we
achieved
targeted
transport
tumor
sites.
Additionally,
dual
near-infrared
(NIR)
irradiation
at
site
facilitated
photosynthesis
in
enabling
breakdown
excessive
intratumoral
generating
oxygen
water
decomposition.
This
process
effectively
reduced
pressure,
thereby
promoting
enhanced
perfusion
blood
into
tumor,
significantly
improving
deep-seated
chemotherapeutic
agents,
alleviating
hypoxia.
Conclusions
CP@ICG
demonstrated
combined
effect
photothermal/photodynamic/starvation
therapy,
exhibiting
excellent
vitro/in
vivo
anti-tumor
efficacy
favorable
biocompatibility.
work
provides
scientific
foundation
for
application
microbial-enhanced
delivery
therapy.
Graphical
ACS Nano,
Год журнала:
2023,
Номер
17(11), С. 10792 - 10805
Опубликована: Июнь 2, 2023
Natural
melanin
nanoparticles
(MNPs)
have
demonstrated
a
potential
for
eliciting
antitumor
immune
responses
through
inducing
immunogenic
cell
death
(ICD);
however,
the
tumor
microenvironment
(TME)
has
been
shown
to
inhibit
T
cell-mediated
immunity.
To
address
this
challenge,
we
designed
TME-responsive
biodegradable
melanin/MnOx
nanohybrids
via
biomineralization
process.
Under
near-infrared
(NIR)
light
irradiation,
photothermal
property
of
triggers
ICD
and
release
tumor-associated
antigens
(TAAs),
while
Mn2+
TAAs
induce
dendritic
(DC)
maturation
provoke
responses.
Furthermore,
immunoregulatory
properties
themselves
are
exploited
reshape
immunosuppressive
TME
downregulate
PD-L1
alleviation
hypoxic
acidic
TME.
Although
MNPs
demonstrate
higher
killing
efficiency
than
in
vitro
due
their
superior
effect,
exhibit
significantly
enhanced
antimetastatic
effects
vivo,
benefiting
from
ability
reverse
immunosuppression
DC
maturation.
Transcriptomics
analysis
confirmed
successful
activation
This
work
presents
promising
approach
immunomodulation-enhanced
cancer
therapy
intrinsic
nanohybrids.
Journal of Nanobiotechnology,
Год журнала:
2023,
Номер
21(1)
Опубликована: Янв. 30, 2023
Immunotherapy
had
demonstrated
inspiring
effects
in
tumor
treatment,
but
only
a
minority
of
people
could
benefit
owing
to
the
hypoxic
and
immune-suppressed
microenvironment
(TME).
Therefore,
there
was
an
urgent
need
for
strategy
that
relieve
hypoxia
increase
infiltration
lymphocytes
simultaneously.
In
this
study,
novel
acidity-responsive
nanoscale
ultrasound
contrast
agent
(L-Arg@PTX
nanodroplets)
constructed
co-deliver
paclitaxel
(PTX)
L-arginine
(L-Arg)
using
homogenization/emulsification
method.
The
L-Arg@PTX
nanodroplets
with
uniform
size
about
300
nm
high
drug
loading
efficiency
displayed
good
diagnostic
imaging
capability,
improved
aggregation
achieved
ultrasound-triggered
release,
which
prevent
premature
leakage
drugs
thus
improve
biosafety.
More
critically,
combination
targeted
microbubble
destruction
(UTMD)
cellular
reactive
oxygen
species
(ROS),
exerted
oxidizing
effect
converted
L-Arg
into
nitric
oxide
(NO),
alleviating
hypoxia,
sensitizing
chemotherapy
increasing
CD8
+
cytotoxic
T
(CTLs)
infiltration.
Combined
chemotherapeutic
PTX-induced
immunogenic
cell
death
(ICD),
promising
enhance
immunotherapy
synergistically
realize
powerful
treatment
effect.
Taken
together,
very
hopeful
vehicle
integrated
delivery,
imaging,
chemoimmunotherapy.
Nano Letters,
Год журнала:
2024,
Номер
24(5), С. 1717 - 1728
Опубликована: Янв. 25, 2024
Surgery
is
the
primary
method
to
treat
malignant
melanoma;
however,
residual
microtumors
that
cannot
be
resected
completely
often
trigger
tumor
recurrence,
causing
tumor-related
mortality
following
melanoma
resection.
Herein,
we
developed
a
feasible
strategy
based
on
combinational
chemoimmunotherapy
by
cross-linking
carboxymethyl
chitosan
(CMCS)-originated
polymetformin
(PolyMetCMCS)
with
cystamine
prepare
stimuli-responsive
nanogel
(PMNG)
owing
disulfide
bond
in
can
cleaved
massive
glutathione
(GSH)
sites.
Then,
chemotherapeutic
agent
doxorubicin
(DOX)
was
loaded
PMNG,
which
followed
hyaluronic
acid
coating
improve
overall
biocompatibility
and
targeting
ability
of
prepared
(D@HPMNG).
Notably,
PMNG
effectively
reshaped
immune
microenvironment
reprogramming
tumor-associated
macrophage
phenotypes
recruiting
intratumoral
CD8+
T
cells
inherited
immunomodulatory
capability
metformin.
Consequently,
D@HPMNG
treatment
remarkably
suppressed
growth
inhibited
its
recurrence
after
surgical
resection,
proposing
promising
solution
for
overcoming
lethal
recurrence.
Nano Letters,
Год журнала:
2022,
Номер
22(15), С. 6409 - 6417
Опубликована: Июль 22, 2022
The
development
of
a
manageable
reactive
nitrogen
species-potentiated
nitrosative
stress
induction
system
for
cancer
therapy
has
remained
elusive.
Herein,
tailored
silica-based
nanoscintillators
were
reported
low-dosage
X-ray
boosting
the
in
situ
formation
highly
cytotoxic
peroxynitrite
(ONOO–).
Significantly,
cellular
revolving
around
intracellular
protein
tyrosine
nitration
through
ONOO–
pathways
was
explored.
High-energy
X-rays
directly
deposited
on
nanoscintillators,
forming
concept
an
open
source
and
reduced
expenditure-aggravated
DNA
damage
strategy.
Moreover,
resultant
ONOO–,
along
with
released
nitric
oxide,
not
only
can
act
as
"oxygen
suppliers"
to
combat
tumor
hypoxia
but
also
induce
mitochondrial
initiate
caspase-mediated
apoptosis,
further
improving
therapeutic
efficacy
radiotherapy.
Thus,
design
advanced
specific
enhanced
offers
promising
potential
postoperative
radiotherapy
colon
cancer.
Advanced Functional Materials,
Год журнала:
2022,
Номер
33(2)
Опубликована: Ноя. 23, 2022
Abstract
Chronic
diseases
claim
millions
of
lives
every
year,
and
it
is
great
significance
to
explore
develop
advanced
drugs
improve
the
cure
rate
chronic
diseases.
Nanotheranostics
are
innovative
strategies
that
enable
integration
diagnostic
therapeutic
properties
into
a
single
nanosystem.
Despite
success
in
nanotheranostics,
their
applications
nanotheranostics
nanomedicine
still
infancy.
This
because
each
disease
has
its
corresponding
characteristic
pathological
microenvironment,
which
motivates
development
endogenous
biomarker‐responsive
nanosystems
meet
requirements
diagnosis
treatment.
Herein,
recent
progress
presented
biomedical
applications.
First,
classified
eight
subsections
according
type
diseases,
including
tumors,
cardiovascular
neurological
Wilson's
liver
kidney
diabetes
mellitus,
rheumatoid
arthritis.
In
following,
variety
intriguing
biomarkers‐responsive
briefly
elaborated,
such
as
biosensing,
diagnosis,
therapy,
combined
theranostics,
early
evaluation
therapy
effect,
etc.
Finally,
challenges
future
directions
from
research
clinical
translation
these
responsive
also
presented.
Abstract
Cancer
immunotherapy
has
been
a
revolutionary
cancer
treatment
modality
because
it
can
not
only
eliminate
primary
tumors
but
also
prevent
metastases
and
recurrent
tumors.
Immunogenic
cell
death
(ICD)
induced
by
various
modalities,
including
chemotherapy,
phototherapy,
radiotherapy,
converts
dead
cells
into
therapeutic
vaccines,
eliciting
systemic
antigen‐specific
antitumor.
However,
the
outcome
effect
of
ICD
limited
due
to
low
accumulation
efficiency
inducers
in
tumor
site
concomitant
damage
normal
tissues.
The
boom
smart
nanomaterials
is
conducive
overcoming
these
hurdles
owing
their
virtues
good
stability,
targeted
lesion
site,
high
bioavailability,
on‐demand
release,
biocompatibility.
Herein,
design
nanomaterials,
inducers,
applications
responsive
different
stimuli,
pH,
enzymes,
reactive
oxygen
species,
or
dual
responses
are
summarized.
Furthermore,
prospect
challenges
briefly
outlined
provide
reference
inspiration
for
designing
novel
ICD.
The
interaction
between
platelets
and
circulating
tumor
cells
(CTCs)
contributes
to
distal
metastasis
by
protecting
CTCs
from
immunological
assault
shear
stress,
which
can
be
disrupted
nitric
oxide
(NO)
through
inhibiting
platelet-mediated
adhesion.
To
eradicate
primitive
tumors
inhibit
CTC-based
pulmonary
metastasis,
a
novel
biomimetic
nanomedicine
(mCuMNO)
is
designed
encapsulating
Cu+
-responsive
S-nitrosoglutathione
as
NO
donor
into
copper-based
metal-organic
framework
(CuM).
This
work
discovers
that
mCuMNO
target
regions
deplete
local
glutathione
(GSH)
reduce
Cu2+
,
followed
triggering
release
hydroxyl
radicals
(·OH)
production,
thereby
interrupting
platelet/CTC
interplay
contributing
chemodynamic
therapy.
Detailed
studies
demonstrate
exhibits
high
efficiency
safety
in
therapy
antimetastasis
activity,
sheding
new
light
on
the
development
of
CuM-based
synthetic